WeVote
Log In

Bill

Bill

S 3320

Relates to extending provisions of law relating to the New York state adult cystic fibrosis program

2025 Regular Session Introduced by Cordell Cleare

New York bill extends the state's adult cystic fibrosis program to maintain healthcare services for adults with this serious genetic lung disease.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 3320

Legislative bill overview

S 3320 extends provisions of law relating to New York State's adult cystic fibrosis program. The bill appears to maintain or modify existing statutory requirements for this specialized healthcare program serving adults with CF in New York. Without access to the full bill text, specific details on what provisions are being extended and for how long remain unclear.

Why is this important

Cystic fibrosis is a serious genetic disorder requiring ongoing, specialized medical care. Program continuity is critical for the approximately 2,000+ adults with CF in New York who depend on coordinated treatment services, care coordination, and potentially subsidized or covered care. Allowing these provisions to lapse could disrupt access to essential pulmonary, nutritional, and multidisciplinary services.

Potential points of contention

  • Fiscal impact unclear: Without seeing the bill text, the cost to the state budget for extending this program is unknown, which could affect legislative priorities and funding debates
  • Scope of extension: Details on which specific provisions are extended, for what duration, and whether benefits or eligibility criteria change are not specified in available information
  • Program adequacy: Questions may arise about whether current program provisions adequately serve the adult CF population or if reforms are needed alongside extension

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.